AcelRx Pharmaceuticals In... (ACRX)
NASDAQ: ACRX
· Real-Time Price · USD
0.86
0.06 (7.50%)
At close: Jan 09, 2024, 10:00 PM
AcelRx Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 6.79M | 5.39M | 8.86M | 11.12M | 13.42M | 5.72M | 13.39M | 7.41M | 13.35M | 15.28M | 12.73M | 15.16M | 21.82M | 12.66M | 13.27M | 26.33M | 34.36M |
Short-Term Investments | n/a | n/a | n/a | n/a | 600K | 3.66M | n/a | n/a | n/a | 495K | 3.19M | 7.76M | 17.53M | 38.97M | 35.43M | 29M | 32.98M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 8.82M | 8.82M | 8.82M | 8.82M | 8.82M | 20K | 20K | 70K | 70K | 246K | 251K | 257K | 261K | 2.17M | 281K | 70K | 70K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15K | 276K | 309K | 512K | 364K | 184K | 160K | 153K | 104K | 658K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11K | 1.12M | 1.18M | 874K | 901K | 1.04M | 1.11M | 1.56M | 1.36M | 1.42M |
Other Current Assets | 905K | 788K | 554K | 1.08M | 2.01M | 2.17M | 1.02M | 1.4M | 525K | 2.31M | 7.23M | 7.81M | 2.23M | 2.59M | 1.34M | 2.18M | 1.89M |
Total Current Assets | 7.7M | 6.18M | 9.42M | 12.2M | 16.04M | 11.56M | 14.42M | 8.84M | 17.35M | 24.57M | 24.54M | 32M | 42.81M | 55.49M | 51.75M | 58.97M | 71.31M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 49K | 13.86M | 14.7M | 15.06M | 20.08M | 20.23M | 20.23M | 20.55M | 15.96M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | 8.82M | 8.82M | 8.82M | 8.82M | 8.82M | 8.82M | 8.82M | 8.82M | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 8.82M | 8.82M | 8.82M | 8.82M | 8.82M | 8.84M | 8.84M | 8.89M | 8.94M | 22.92M | 23.77M | 24.14M | 29.16M | 22.4M | 20.51M | 20.62M | 16.03M |
Total Assets | 16.52M | 14.99M | 18.24M | 21.01M | 24.86M | 20.39M | 23.26M | 17.73M | 26.29M | 47.49M | 48.31M | 56.13M | 71.97M | 77.89M | 72.26M | 79.59M | 87.35M |
Account Payables | 835K | 326K | 670K | 396K | 808K | 1.34M | 1.03M | 1.21M | 1.4M | 2.04M | 2M | 2.4M | 2.71M | 2.12M | 2.23M | 1.94M | 3.23M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.12M | 115K | 1.06M | 1.09M | 1.12M | 86K | 1.24M | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.37M | 7.46M | 9.25M | 11.03M | 10M | 9.86M | 9.51M | 9.27M | 9.03M |
Other Current Liabilities | 2.63M | 1.99M | 2.65M | 2.76M | 2.47M | 731K | 2.55M | 3.01M | 3.57M | 4.15M | 3.34M | 3.17M | 3.2M | 6.44M | 4.1M | 3.98M | 3.28M |
Total Current Liabilities | 2.63M | 1.99M | 2.65M | 2.76M | 3.27M | 4.51M | 3.57M | 4.22M | 9.46M | 13.77M | 15.65M | 17.69M | 17.03M | 18.51M | 17.07M | 15.19M | 15.54M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.96M | 3.23M | 3.36M | 6.62M | 8.76M | 10.89M | 13.49M | 11.34M |
Other Long-Term Liabilities | 7.26M | 7.41M | 7.59M | 8.61M | 8.85M | n/a | 1.38M | n/a | 2.59M | 7.91M | 827K | 849K | 85.47M | 81K | 109K | 86.9M | 87.78M |
Total Long-Term Liabilities | 7.26M | 7.41M | 7.59M | 8.61M | 8.85M | 1.78M | 1.38M | 3.09M | 2.59M | 11.9M | 5.12M | 5.3M | 93.21M | 95.28M | 98.21M | 100.39M | 99.11M |
Total Liabilities | 9.89M | 9.4M | 10.23M | 11.37M | 12.13M | 6.29M | 4.95M | 7.31M | 12.05M | 25.67M | 20.77M | 22.99M | 110.24M | 113.79M | 115.28M | 115.58M | 114.66M |
Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.37M | 10.42M | 12.47M | 14.39M | 16.62M | 18.62M | 20.4M | 22.76M | 20.37M |
Common Stock | 20K | 17K | 17K | 17K | 17K | 17K | 17K | 11K | 11K | 8K | 7K | 147K | 147K | 137K | 119K | 119K | 118K |
Retained Earnings | -463.31M | -459.82M | -457.23M | -455.36M | -452.01M | -444.23M | -439.71M | -438.35M | -433.98M | -425.83M | -418.35M | -411.6M | -482.26M | -473.58M | -465.67M | -457.29M | -447.44M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 6.63M | 5.6M | 8M | 9.64M | 12.73M | 14.11M | 18.31M | 10.42M | 14.24M | 21.81M | 27.54M | 33.14M | -38.27M | -35.89M | -43.02M | -35.99M | -27.31M |
Total Investments | n/a | n/a | n/a | n/a | n/a | 3.66M | n/a | n/a | n/a | 495K | 3.19M | 7.76M | 17.53M | 38.97M | 35.43M | 29M | 32.98M |